curculigoside

01/01/2016 - "The purpose of this study was to investigate the protective effects of curculigoside A (CA) on adjuvant arthritis (AA) rats and explore its possible mechanisms. "

01/01/2016 - "The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-кB/NLRP3 activation in rats."
03/01/2019 - "The results revealed that curculigoside inhibited paw swelling and arthritis scores in type II collagen‑induced arthritic (CIA) rats. "

05/01/2020 - "Curculigoside pre‑treatment significantly improved cell viability, decreased cell apoptosis and LDH activity, and reduced the infarct size and myocardial apoptosis in vitro and ex vivo, respectively. "

01/30/2023 - "To explore the efficacy of curculigoside in protecting against ischemic brain injury (IBI) through the regulation of oxidative stress and NF-κB and PI3K/Akt expression. "
01/30/2023 - "Efficacy of curculigoside in protecting against ischemic brain injury through regulation of oxidative stress and NF-κB and PI3K/Akt expression."

10/25/2023 - "This work aims to study the function of curculigoside in osteoporosis and explore whether DNMT1 is closely involved in osteoblast activity. "
09/09/2019 - "[Study on the effect of curculigoside on osteoporosis]."
10/25/2023 - "Curculigoside attenuates osteoporosis through regulating DNMT1 mediated osteoblast activity."
04/26/2021 - "Finally, we established an ovariectomized (OVX)-induced osteoporosis mouse model and administered curculigoside to explore the effects of curculigoside in preventing bone loss in vivo. "
04/26/2021 - "Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis."